维普中文期刊产品整合服务
16篇 您的检索式:作者名="zimbroff DL"
    题名 作者 年代 出处 被引量
1Zip 80 mg/d and 160 mg/d in the acute exacerbation of schizophrenia and schizoaffective disorder:A6 week placebo controlled trial zip study group显示文摘Daniel DG zimbroff DL potkin SG 1999Neuropsychopharmacology1999,20,5:1
2Zip 80mg/d and 160mg/d in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6 week placebo controlled trial zip study group 显示文摘Daniel DG Zimbroff DL Potkin SG 1999Neuropsychophar macology1999,20,5:1
3Controlled,dose - response study of sertindole and haloperidol in the treatment of schizophrenia显示文摘Zimbroff DL Kane JM Tamminga CA 1997Am J Psychiatry1997,154,:1
4Bset clinical practice with ziprasidone IM:update after 2 years of experience显示文摘ZIMBROFF DL ALLEN MH BATTAGLIA J 2005CNS Spectr2005,10,9:1
5Zip 80mg/d and 160mg/d in the acute exacerbation of schizophrenia and sehizoaffective disorder: A 6 week placebo controlled trial zip study group显示文摘Daniel DG zimbroff DL potkin SG 1999Neuropsychop]larn/a- cology1999,20,5:1
6The tolera- bility of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy 显示文摘Daniel DG Zimbroff DL Swift RH 2004Int Clin Psychophar- macol2004,19,1:1
7Bases clinical practice with ziprasidone IM:update after 2 years of experience显示文摘 ALLEN MH BATTAGLIA J 2005CNS Sperctr2005,10,9:1
8Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder:a 6-week placebo-controlled trial显示文摘Daniel DG Zimbroff Dl Potkin SG 1999Neuropsychopharmacology1999,20,:1
9The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy显示文摘Daniel DG Zimbroff DL Swift RH 0,,:1
10Pharmacological control of acute agitation:Focus on intra-muscular preparations显示文摘Zimbroff DL 0,,:1
11Pharmacological control of acute agitation: focus on intramuscular preparations 显示文摘Zimbroff DL 2008CNS Drugs2008,22,3:1
12Controlled,dose-response study of sertindole and haloperidol in the treatment of schizophrenia显示文摘 Kane JM Tamminga CA 1997Am J Psychi atry1997,154,:1
13Best clinical practice with ziprasidone IM:update after 2 years of experience显示文摘Zimbroff Dl Allen MH Battaglia J 2005CNS Spectr2005,10,9:1
14Ziprasidone 80mg/day and 160mg/day in the acute exacerbation of schizophrenia Ziprasidone Study Group显示文摘DANIEL DG ZIMBROFF DL POTKIN SG 1999Neuropsychopharmacol1999,20,5:1
15Best clinical practice with ziprasidone IM:update after 2 years of experience显示文摘Zimbroff DL Allen MH 2005CNS Spectr2005,10,:1
16Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder:a six-week placebo-controlled trial显示文摘Daniel DG ZIMBROFF DL POTKIN SG 0,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费